No Data
No Data
Institutional Investors May Overlook Novavax, Inc.'s (NASDAQ:NVAX) Recent US$135m Market Cap Drop as Long-term Gains Remain Positive
TD Cowen Initiates Novavax(NVAX.US) With Hold Rating, Announces Target Price $9
Novavax: Promising Innovations Amidst Execution and Competitive Challenges – Hold Rating
Novavax Inc. Stock Slips 7.3%, Underperforms Competitors
What's in Store for These 5 Biotech Stocks This Earnings Season?
Earnings Preview: Novavax to Report Financial Results Pre-market on February 27